Blog

Unlike conventional vaccines, this vaccine is delivered through the nose, allowing it to stimulate immune responses directly in the respiratory tract – the primary site where TB bacteria enter and infect the body. The vaccine is specifically designed to target TB persister bacteria, hard-to-kill bacteria that survive antibiotic treatment, remain dormant, and often trigger relapse after therapy ends.